The bill aimed to have the Agency for Health Care Administration (AHCA) conduct a study on discounted drug pricing. This study was supposed to gather specific information about drug prices and report the findings to the Governor and the Legislature by a set deadline. However, the bill did not pass.
FL H0573 is a house bill in the Florida 2026 Sixth Special Session, sponsored by Linda Chaney (R), currently “Failed” since March 13, 2026.
We track 326 Florida bills this session, 2 of them sponsored by Linda Chaney.
Supporters of the bill would argue that it was a necessary step toward understanding and improving access to affordable medications for Floridians. They would emphasize the importance of data-driven decisions in healthcare policy, which could lead to better pricing strategies and ultimately lower costs for consumers.
Critics might contend that the bill represented unnecessary government intervention in the pharmaceutical market. They could argue that such studies often lead to delays in addressing urgent healthcare needs and that the focus should be on immediate solutions rather than research.
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Florida Legislature. Conflict-of-interest analysis for this bill is coming soon.
What does FL H0573 do?
The bill aimed to have the Agency for Health Care Administration (AHCA) conduct a study on discounted drug pricing. This study was supposed to gather specific information about drug prices and report the findings to the Governor and the Legislature by a set deadline. However, the bill did not pass.
What is the status of FL H0573?
FL H0573 is currently “Failed” in the Florida legislature.
Who sponsored FL H0573?
Linda Chaney (R) sponsored FL H0573.
FL H0573